-REGENERON ESMO IO PRESENTATIONS HIGHLIGHT POTENTIAL OF FIANLIMAB AND LIBTAYO IN MULTIPLE SOLID TUMOR TYPES

  • Israel Lowy,

Press/Media

Period2 Dec 2022

Media coverage

3

Media coverage